TACSTD2 and cervical cancer: Intriguingly, the expression of TROP2 was gradually increased from CINI (50%) to CINII (66.7%) and CINIII (76.9%; Figure 1C) (p = 0.037), indicating TROP2 expression was significantly correlated with the development and progression of cervical cancer.